Please login to the form below
Mimpara
This page shows the latest Mimpara news and features for those working in and with pharma, biotech and healthcare.
NICE set to back Parsabiv for kidney disease complication
be treated with Amgen's older drug Sensipar/Mimpara (cinacalcet) - and provided Amgen supplies the drug at an agreed discount.
Latest news
-
Amgen's chronic kidney disease drug Parsabiv cleared in US
Parsabiv (etelcalcetide) - a follow-up to Amgen's blockbuster Sensipar/Mimpara (cinacalcet) - has been given a green light to treat adult CKD patients on dialysis who develop secondary hyperparathyroidism (sHPT).
-
Amgen wins European approval for Parsabiv
Sensipar/Mimpara blockbuster.
-
FDA knocks back Amgen's chronic kidney disease treatment
up to blockbuster Sensipar/Mimpara.
-
CHMP recommends 19 new medicines for European approval
of Amgen's hyperparathyroidism and parathyroid carcinoma drug Mimpara.
-
Amgen's Sensipar follow-up clears phase III trial
AMG 416 meets objectives in hyperparathyroidism. One of the unsung heroes in Amgen's product portfolio is Sensipar/Mimpara for secondary hyperparathyroidism (HPT), which has grown fairly steadily since its launch
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
PAN and DJM win prestigious Global Award
Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their animation of Mimpara Man’ for Amgen. ... Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- Novartis to test canakinumab for COVID-19, as IL-6 trial disappoints
- Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
- UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
- NICE approves Roche’s Tecentriq in TNBC after revising deal
- IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- The big issue
- The field team are off the road! What should they do next?
- INFOGRAPHIC 02: The Importance of clinical study websites
PMHub
90TEN
90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...
Latest intelligence
- The big issue
- Whether you want to lead or follow, you need to understand the elephant in the C-suite...
- INFOGRAPHIC 02: The Importance of clinical study websites
- Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
- Working with, Advocating for, and Empowering Patients
- A holistic view of how to work with patients virtually...
Quick links
Infographics
